|« Previous month||Next month »|
31-Mar-2014 - GSK says it intends to build five new drug manufacturing as part of a £130m ($215m) investment in sub-Saharan Africa.
31-Mar-2014 - Baxter says it will spin out its pharma business to form two separate companies by 2015.
31-Mar-2014 - In light of the implementation of the Drug Quality and Security Act of 2013 in the US, which calls for the phased implementation of electronic tracking down to the package...
31-Mar-2014 - The rapid growth of the US excipients market is going to be driven mostly by rises in polymers, gelatins and sugar alcohols, according to a new study.
31-Mar-2014 - People are on the move at Baxter, Merck & Co., Johnson & Johnson, and elsewhere in this week's column.
31-Mar-2014 - Hospira has agreed to pay $60m (€44m) to settle a lawsuit related to manufacturing and quality control deficiencies at its Rocky Mount facility, which is already subject to a $200m...
27-Mar-2014 - ADC-makers could avoid using costly cytotoxics in antibody-drug conjugates (ADCs) by using near‐infrared (NIR) light to activate targeted cell-killing payloads, says Goodwin who has team up with Aspyrian Therapeutics....
27-Mar-2014 - GlaxoSmithKline has issued an alert and US voluntary recall of its OTC weight-loss drug Alli after discovering some bottles had been tampered with.
26-Mar-2014 - GSK has ‘smashed’ production targets at a UK inhaler plant by revving up manufacturing operations with knowhow developed in Formula One pit lanes by partner, McLaren.
26-Mar-2014 - Pharmaceutical firms working in Europe may need to update their address books next month after more reorganisation at the EMA.
25-Mar-2014 - The US FDA has published guidance of how sponsors should best document the bioavailability of products for investigational new drug applications (INDs) and new drug applications (NDAs).
25-Mar-2014 - Failure in maintaining test and production data has landed an Indian API maker with a Warning Letter from the US Food and Drug Administration (FDA).
25-Mar-2014 - AMRI will acquire Cedarburg Pharmaceuticals for $38.2m (€27.7) in cash, plus $2.8m of assumed liabilities, to expand its API and drug development offerings.
24-Mar-2014 - Japan has become the first country to approve a new cancer pill that treats disease by interfering with DNA replication in tumour cells.
24-Mar-2014 - The thin profit margins associated with relatively simple sterile products has led to a reluctance to invest in operations and shortages, according to an industry expert.
24-Mar-2014 - New hires at Merck Serono, Amgen, Takeda and Fate Therapeutics this week. It's in-Pharmatechnologist.com's people column.
20-Mar-2014 - Efforts to cut industrial energy bills in the UK's 2014 Budget have been welcomed by the Chemical Industries Association (CIA), a group whose members include drug and ingredient makers.
20-Mar-2014 - Drugmakers were replaced by buyers of cosmetics, hygiene and material protection ingredients as Lonza’s biggest customers in 2013 according to a report released by the Swiss CMO today.
20-Mar-2014 - The UK Medicines and Healthcare Products Regulatory Agency (MHRA) will launch a scheme next month to allow doctors to prescribe medicines without a marketing authorisation to patients with life-threatening conditions.
19-Mar-2014 - .
19-Mar-2014 - ‘Podular’ manufacturing systems will dominate facility design within five years, say G-CON and GEA who have teamed with Pfizer to create a flexible, repurposable and portable facility.
19-Mar-2014 - US pharmaceutical firms ‘fear change’ and need guidance on assessing safe excipient supply to become more like their European counterparts, says a senior IPEC expert.
19-Mar-2014 - Aegis Therapeutics claims a technology developed to improve the bioavailability of drugs delivered through the nose has a similar solubility enhancement effect in a solid dosage form.
18-Mar-2014 - Caisson Biotech has licensed its drug-extending technology for injectables to Novo Nordisk.
18-Mar-2014 - The Board of Directors at Indian firm Orchid has approved the sale of its API business to Hospira, bringing the acquisition a step closer to completion.
|« Previous month||Next month »|